Main Street Group’s BridgeBio Pharma BBIO Stock Holding History

Main Street Group’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.45K	Hold	100	–	–	﹤0.01%	594
2026 Q1	$7.43K	Buy	+100	New	+$7.25K	﹤0.01%	582
2025 Q4	–	Sell	-100	Closed	-$5.19K	–	135
2025 Q3	$5.19K	Hold	100	–	–	﹤0.01%	612
2025 Q2	$4.32K	Buy	+100	New	+$3.64K	﹤0.01%	593

Other funds holding BBIO

Jupiter Topco New York $245B AUM

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Main Street Group's BBIO Position: Q2 2026 in Review

Main Street Group held its BridgeBio Pharma (BBIO) position steady in Q2 2026 at 100 shares worth $7.45K. The position accounts for ﹤0.01% of the portfolio, ranked #594.

Main Street Group first reported a position in BBIO in Q2 2025 and has held it in 4 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

Main Street Group held 100 shares of BridgeBio Pharma worth $7.45K as of Q2 2026.
Main Street Group left its BridgeBio Pharma share count unchanged in Q2 2026.
BridgeBio Pharma made up ﹤0.01% of Main Street Group's portfolio in Q2 2026, its #594 holding.
Main Street Group first reported a position in BridgeBio Pharma in Q2 2025 and has held it in 4 quarters since.
474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.